A Durham-based biopharmaceutical company says it has gotten the okay from the Food and Drug Administration to test its experimental cancer drug on COVID-19 patients in the U.S. The company, Chimerix, believes the drug, originally designed for acute myeloid leukemia, could address lung inflammation in COVID-19 patients as well as blood coagulation issues. The drug, DSTAT, is […]

Five biopharmaceutical industry CEOs discuss challenges their company’s have faced, along with best practices implemented in managing through the COVID-19 chaos […]

It’s early, not even 7 a.m., in fact, and the above statement is prefaced with an apology for interrupting the free-flowing dialogue taking place between a gathering of five biopharmaceutical executives on day two of the 2020 J.P. Morgan Healthcare Conference (JPM). Among the incessant ringing of nearby cell phones, conversations, and the echo of […]